Hidden Link: How Gut Health Influences Asthma and COPD Treatment Outcomes Introduction Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of morbidity and mortality worldwide, currently affecting more than 400 million people. It is characterized by progressive inflammation, structural lung destruction,
Tag: COPD
Salbutamol: A Safety Meta-Analysis
Salbutamol: A Safety Meta-Analysis Overview Salbutamol, a widely used bronchospasm reliever, has been insufficiently scrutinized for potential risks. In a meta-analysis of 58 randomized controlled trials with 12,961 participants, the study unearthed a 34% incidence of total adverse events (AEs). Notably, severe AEs stood at 2%, and treatment discontinuation was 3%. Subgroup
COPD Risk With Diabetes And Pre-Diabetes
COPD Risk With Diabetes And Pre-Diabetes A new trail-blazing study links diabetes, pre-diabetic states, and an extended duration of diabetes to an increased risk of chronic obstructive pulmonary disease development. This article will explore this ground-breaking research and its findings. Background of the Study Diabetes and chronic obstructive pulmonary diseases (COPD) are among
